Daniel Markowitz
Stock Analyst at Evercore ISI Group
(1.75)
# 2,894
Out of 4,915 analysts
6
Total ratings
50%
Success rate
2.18%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Initiates: Outperform | $170 | $140.96 | +20.60% | 1 | Jul 28, 2025 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $275 → $350 | $249.21 | +40.44% | 2 | Jul 25, 2025 | |
| RGEN Repligen | Maintains: In-Line | $140 → $130 | $122.85 | +5.82% | 2 | Jul 8, 2025 | |
| TECH Bio-Techne | Initiates: Outperform | $75 | $57.71 | +29.96% | 1 | Mar 18, 2025 |
Natera
Jul 28, 2025
Initiates: Outperform
Price Target: $170
Current: $140.96
Upside: +20.60%
West Pharmaceutical Services
Jul 25, 2025
Maintains: Outperform
Price Target: $275 → $350
Current: $249.21
Upside: +40.44%
Repligen
Jul 8, 2025
Maintains: In-Line
Price Target: $140 → $130
Current: $122.85
Upside: +5.82%
Bio-Techne
Mar 18, 2025
Initiates: Outperform
Price Target: $75
Current: $57.71
Upside: +29.96%